Abstract
Purpose: We recently showed that prophylactic breast irradiation (PBI) reduces the risk of contralateral breast cancer in BRCA mutation carriers undergoing treatment for early breast cancer. It has been suggested that Background Parenchymal Enhancement (BPE) may be a biomarker for increased risk of breast cancer. Methods: For participants in the trial we reviewed the MRI prior to enrollment and following radiation treatment and scored the contralateral breast for BPE and density. Results: Significant reduction of BPE was more commonly noted following PBI (p = 0.011) compared to the control group. Conclusion: Reduction of BPE by PBI may contribute to its prophylactic effect.
Original language | English |
---|---|
Pages (from-to) | 70-73 |
Number of pages | 4 |
Journal | Breast |
Volume | 49 |
DOIs | |
State | Published - Feb 2020 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 The Authors
Funding
This work was supported by the Israel Cancer Association, grant No. C-20190082.
Funders | Funder number |
---|---|
Israel Cancer Association | C-20190082 |
Keywords
- BPE
- BRCA
- Breast cancer
- Prophylactic breast irradiation